Alnylam Pharmaceuticals, Inc.
ALNY · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $251 | -$66 | -$57 | -$84 |
| Dep. & Amort. | $14 | $14 | $14 | -$21 |
| Deferred Tax | $6 | $10 | $10 | $0 |
| Stock-Based Comp. | $108 | $112 | $57 | $92 |
| Change in WC | -$205 | $50 | -$217 | -$74 |
| Other Non-Cash | $151 | $35 | $75 | -$8 |
| Operating Cash Flow | $325 | $154 | -$118 | -$95 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$12 | -$14 | -$9 | -$9 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$210 | -$469 | -$450 | -$487 |
| Inv. Sales/Matur. | $723 | $332 | $524 | $443 |
| Other Inv. Act. | -$0 | $9 | $49 | -$0 |
| Investing Cash Flow | $501 | -$141 | $114 | -$53 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$494 | $0 | $0 | $0 |
| Stock Issued | -$131 | $81 | $49 | $36 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $176 | -$27 | -$5 | -$5 |
| Financing Cash Flow | -$448 | $54 | $44 | $31 |
| Forex Effect | -$1 | $28 | $14 | -$17 |
| Net Chg. in Cash | $377 | $94 | $54 | -$134 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,116 | $1,022 | $969 | $1,102 |
| End Cash | $1,493 | $1,116 | $1,022 | $969 |
| Free Cash Flow | $313 | $139 | -$127 | -$104 |